Nervelin Reviews

From the distributor, in one file, as a summary. 4.8 out of five across 737 written reviews, set against 9,500 orders, with 88% of those who wrote saying they would buy again. Those four numbers arrived already added up.

A summary is a useful thing and a limited one. It tells you the shape of the response and it cannot be audited, because the transcripts behind it are the seller’s property and were never handed over. This desk prints the four figures as the seller’s own and labels them that way in the footer of every page, which is a different thing from standing behind them.

One ratio is worth doing in your head before you read anything else. 737 written reviews against 9,500 orders is roughly one buyer in thirteen writing anything down. That is a normal rate for a capsule bought online, and it means the people on this page are the ones who felt strongly enough to type, in both directions.

Eight buyers, three distinct comment bodies between them. The wording is the distributor’s summary copy, reproduced rather than rewritten, which is why three of the eight read word for word alike.

Half the roster is over 55, which fits a nerve-comfort category more than it fits the testosterone stack the back panel actually prints. The days-in column is the useful one: the median buyer on this list had been taking it 37 days when the comment was collected, which is long enough for a first bottle to have run out and a second to have been opened.

Three of the eight bought six bottles and two bought two. Nobody on this roster is described as a first-week buyer, and nobody on it is described as a two-year one. The window this feedback covers is the first six months, which is also the window the ordering ladder is built around.

Two thirds at five stars, a fifth at four, and 13% at three or below. That last group is the informative one, because a capsule that nobody rated badly would be a capsule whose feedback had been filtered.

What the low scores say is consistent enough to name. 2 of the 8 buyers here wanted a faster change than arrived and stopped early; nobody on the roster reports a reaction, a delivery problem or a billing dispute. A low score for disappointment and a low score for a fault are different failures, and only one of them is on this list.

Eight buyers, three bodies. Counting them is more honest than printing eight cards that would look like eight separate opinions.

3 buyers describe the routine sticking and a reorder placed before the last bottle ran out. 3 call it fair at a month while saying they wanted more from week one. 2 wanted a faster change, called the desk, and stopped at two bottles. That is the whole of the feedback, and stating it in three lines is the most accurate thing this page can do with it.

The three themes disagree about one thing and agree about everything else. They disagree about whether the wait was acceptable. They agree that the capsule was easy to take, that nothing went wrong with it, and that the first week was quiet.

The thing a reader most wants them to settle, which is whether the blend does anything. Feedback measures satisfaction, and satisfaction and effect are different measurements with different error bars.

The gap on the last two rows is the reason the rest of this website is built the way it is. Nine botanicals share one weight, and the amounts the published trials used sit on the ingredients page beside each of them. The Tongkat Ali trial ran at 200 mg a day. The Epimedium trial ran at 740 mg a day. Four ingredients at the lower figure their own trials used want 2,740 mg between them, and the blend is 1,000 mg with five more names in it.

So read the roster for what it is good for. It will tell you whether the routine is livable and whether the desk picks up the telephone. For the other question, the panel and the trial doses beside it are the only honest material anyone has.